Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

MyNCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

539 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Regression of paclitaxel-induced maculopathy with oral acetazolamide.
Meyer KM, Klink T, Ugurel S, Bröcker EB. Meyer KM, et al. Among authors: Brocker EB. Graefes Arch Clin Exp Ophthalmol. 2012 Mar;250(3):463-4. doi: 10.1007/s00417-011-1642-8. Epub 2011 Mar 23. Graefes Arch Clin Exp Ophthalmol. 2012. PMID: 21431400 No abstract available.
Management of primary and metastasized melanoma in Germany in the time period 1976-2005: an analysis of the Central Malignant Melanoma Registry of the German Dermatological Society.
Schwager SS, Leiter U, Buettner PG, Voit C, Marsch W, Gutzmer R, Näher H, Gollnick H, Bröcker EB, Garbe C. Schwager SS, et al. Among authors: Brocker EB. Melanoma Res. 2008 Apr;18(2):112-9. doi: 10.1097/CMR.0b013e3282f623f1. Melanoma Res. 2008. PMID: 18337647
Palliative therapy of melanoma patients with fotemustine. Inverse relationship between tumour load and treatment effectiveness. A multicentre phase II trial of the EORTC-Melanoma Cooperative Group (MCG).
Kleeberg UR, Engel E, Israels P, Bröcker EB, Tilgen W, Kennes C, Gérard B, Lejeune F, Glabbeke MV, Lentz MA. Kleeberg UR, et al. Among authors: Brocker EB. Melanoma Res. 1995 Jun;5(3):195-200. doi: 10.1097/00008390-199506000-00009. Melanoma Res. 1995. PMID: 7543785 Clinical Trial.
539 results
Jump to page
Feedback